Cingulate stock reaffirmed at Buy by H.C. Wainwright ahead of FDA decision

Cingulate stock reaffirmed at Buy by H.C. Wainwright ahead of FDA decision

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.